[HTML] nih.gov

[HTML][HTML] Ketamine for treatment of mood disorders and suicidality: a narrative review of recent progress

MD Kritzer, NA Mischel, JR Young, CS Lai… - Annals of clinical …, 2022 - ncbi.nlm.nih.gov
BACKGROUND: Mood disorders are a leading cause of morbidity. Many patients
experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting …
被引用次数：29 相关文章

Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress.

MD Kritzer, NA Mischel, JR Young, CS Lai… - Annals of Clinical …, 2022 - europepmc.org
Background Mood disorders are a leading cause of morbidity. Many patients experience
treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting and more …

Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progress

MD Kritzer, NA Mischel, JR Young… - Annals of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Mood disorders are a leading cause of morbidity. Many patients experience
treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting and more …

Ketamine for treatment of mood disorders and suicidality: a narrative review of recent progress

MD Kritzer, NA Mischel, JR Young, CS Lai… - Annals of clinical …, 2022 - safetylit.org
BACKGROUND: Mood disorders are a leading cause of morbidity. Many patients
experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting …

Ketamine for treatment of mood disorders and suicidality: a narrative review of recent progress

MD Kritzer, NA Mischel, JR Young, CS Lai… - Annals of clinical …, 2022 - safetylit.org
BACKGROUND: Mood disorders are a leading cause of morbidity. Many patients
experience treatment-resistant depression (TRD), and suicide rates are rising. Faster-acting …